US2006263457A1PendingUtilityA1

Pharmaceutical composition for treatment of emiction disorders caused by benign prostate hyperplasia (BPH) and the method

Assignee: BEIJING WONNER BIOTECH LTD COPriority: Mar 28, 2003Filed: Jun 14, 2006Published: Nov 23, 2006
Est. expiryMar 28, 2023(expired)· nominal 20-yr term from priority
A61K 36/482A61K 36/484A61P 13/08A61K 36/258A61K 36/54A61K 36/16
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition with higher curative effect on benign prostate hyperplasia and emiction disorders is disclosed. It uses plants such as ginseng and gingko as well as cassia twig, cinnamon and liquorices both for food and medicine as raw materials. These raw materials are decocted or extracted separately in ethanol solution or water, then concentrated and dried to make the said pharmaceutical composition. Because this pharmaceutical composition is not toxic and has no side effect, it can be prepared as a medicament and healthy food to treat and improve benign prostate hyperplasia and emiction disorders caused by benign prostate hyperplasia.

Claims

exact text as granted — not AI-modified
1 - 8 . (canceled)  
     
     
         9 . A pharmaceutical extract, characterized by that the extract is obtained by the following steps of: 
 soaking and extracting 9-45 weight shares of ginseng in ethanol or water, following by separation and purification by means of chromatography and drying to get a first extract;    soaking and extracting 20-100 weight shares of core of gingko in ethanol solution or water, following by separation and purification by means of chromatography and drying to get a second extract;    mixing the first extract and the second extract following by crushing and sieving to get said pharmaceutical extract.    
     
     
         10 . The pharmaceutical extract of  claim 9 , wherein said first extract is obtained from 18-36 shares of ginseng and said second extract is obtained from 40-80 shares of core of gingko based on the weight ratio.  
     
     
         11 . The pharmaceutical extract of  claim 9 , wherein said first extract is obtained from 27 shares of ginseng and said second extract is obtained from 60 shares of core of gingko based on the weight ratio.  
     
     
         12 . The pharmaceutical extract of  claim 9 , further comprising a third extract obtained from the water or ethanol extract from addition of 2-30 shares of cinnamon and 2-10 shares of liquorices.  
     
     
         13 . The pharmaceutical extract of  claim 9 , further comprising a fourth extract obtained from the water or ethanol extract from 6-12 shares of cassia twig.  
     
     
         14 . The pharmaceutical extract of  claim 9 , wherein the said extract is prepared as any medicament type pharmaceutically.  
     
     
         15 . The pharmaceutical extract of  claim 9 , comprising pharmaceutically acceptable carriers.  
     
     
         16 . (canceled)  
     
     
         17 . A method of preparation of a pharmaceutical extract, comprising the following steps of: 
 soaking and extracting 9-45 weight shares of ginseng in ethanol or water, following by separation and purification by means of chromatography and drying to get a first extract;    soaking and extracting 20-100 weight shares of core of gingko in ethanol solution or water, following by separation and purification by means of chromatography and drying to get a second extract;    mixing the first extract and the second extract.    
     
     
         18 . The method of  claim 17 , further comprising extracting 2-30 weight shares of cinnamon and 2-10 weight shares of liquorices in water or ethanol to have a third extract, and mixing the first extract and the second extract with the third extract.  
     
     
         19 . The method of  claim 18 , further comprising extracting 6-12 weight shares of cassia twig in water or ethanol to have a fourth extract, and mixing the first extract, the second extract and the third extract with the fourth extract.  
     
     
         20 - 22 . (canceled)  
     
     
         23 . The use of the pharmaceutical extract of  claim 9  in preparation of medicament for improvement and treatment of emiction disorders caused by BHP.  
     
     
         24 . The use of the pharmaceutical extract of  claim 9  in production of food and healthy food.  
     
     
         25 . (canceled)  
     
     
         26 . The method of  claim 17 , wherein said first extract is obtained from 18-36 weight shares of ginseng and said second extract is obtained from 40-80 weight shares of core of gingko based on the weight ratio.  
     
     
         27 . The method of  claim 17 , wherein said first extract is obtained from 27 weight shares of ginseng and said second extract is obtained from 60 weight shares of core of gingko based on the weight ratio.

Join the waitlist — get patent alerts

Track US2006263457A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.